The ADC binds B7-H3 (CD276) on tumor cells, is internalized, and releases a topoisomerase I inhibitor that induces DNA damage and cell death. Topoisomerase I is the intracellular enzyme inhibited by the payload, not the surface antigen targeted for cell killing.